Samsung Biologics, AstraZeneca ink manufacturing deal

By The Science Advisory Board staff writers

September 22, 2020 -- Samsung Biologics and AstraZeneca have signed a $330.8 million long-term supply agreement.

Under terms of the deal, Samsung will provide commercial manufacturing of drug substance and drug product for AstraZeneca's biologics under development; Samsung's remuneration could increase to $545.6 million.

The arrangement will boost AstraZeneca's biologics manufacturing capabilities in the Asia Pacific region, AstraZeneca said.

PharmAbcine, Samsung Biologics expand partnership
PharmAbcine and Samsung Biologics have entered into a new strategic partnership for the development and manufacturing of PMC-403, a next-generation antibody...
AstraZeneca begins phase III trial of its COVID-19 vaccine
AstraZeneca has begun a multisite phase III clinical trial evaluation of its investigational COVID-19 vaccine, AZD1222.
Catalent to support AstraZeneca COVID-19 vaccine manufacturing
Catalent and AstraZeneca have signed an agreement to expand manufacturing support for an adenovirus vector-based COVID-19 vaccine from the University...
Samsung Biologics adds new manufacturing plant
Samsung Biologics announced that it plans to break ground on a fourth plant in South Korea this year as part of a strategy to scale up development and...
Samsung Biologics, Vir partner on SARS-CoV-2 program
Samsung Biologics announced it will manufacture Vir Biotechnology's SARS-CoV-2 monoclonal antibody program for a potential COVID-19 treatment.

Copyright © 2020 scienceboard.net


Conferences
Interphex 2021
October 19-21
New York City, New York United States
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter